Literature DB >> 26771116

Obesity and Cancer: The Oil that Feeds the Flame.

Joan Font-Burgada1, Beicheng Sun2, Michael Karin3.   

Abstract

Although discussion of the obesity epidemic had become a cocktail party cliché, its impact on public health cannot be dismissed. In the past decade, cancer had joined the list of chronic debilitating diseases whose risk is substantially increased by hypernutrition. Here we discuss recent advances in understanding how obesity increases cancer risk and propose a unifying hypothesis according to which the major tumor-promoting mechanism triggered by hypernutrition is the indolent inflammation that takes place at particular organ sites, including liver, pancreas, and gastrointestinal tract. The mechanisms by which excessive fat deposition feeds this tumor-promoting inflammatory flame are diverse and tissue specific.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26771116     DOI: 10.1016/j.cmet.2015.12.015

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  113 in total

1.  STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Authors:  Chunyan Zhang; Chanyu Yue; Andreas Herrmann; Jieun Song; Colt Egelston; Tianyi Wang; Zhifang Zhang; Wenzhao Li; Heehyoung Lee; Maryam Aftabizadeh; Yi Jia Li; Peter P Lee; Stephen Forman; George Somlo; Peiguo Chu; Laura Kruper; Joanne Mortimer; Dave S B Hoon; Wendong Huang; Saul Priceman; Hua Yu
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

Review 2.  Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.

Authors:  Daniel F J Ketelhuth; Esther Lutgens; Magnus Bäck; Christoph J Binder; Jan Van den Bossche; Carolin Daniel; Ingrid E Dumitriu; Imo Hoefer; Peter Libby; Luke O'Neill; Christian Weber; Paul C Evans
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

3.  Novel behavioral interventions to improve long-term weight loss: A randomized trial of acceptance and commitment therapy or self-regulation for weight loss maintenance.

Authors:  J Lillis; S Dunsiger; J G Thomas; K M Ross; R R Wing
Journal:  J Behav Med       Date:  2021-03-27

Review 4.  How does the social environment during life course embody in and influence the development of cancer?

Authors:  Ming Chen; Huiyun Zhu; Yiqi Du; Geliang Yang
Journal:  Int J Public Health       Date:  2018-06-11       Impact factor: 3.380

Review 5.  Molecular mechanisms of the preventable causes of cancer in the United States.

Authors:  Erica A Golemis; Paul Scheet; Tim N Beck; Eward M Scolnick; David J Hunter; Ernest Hawk; Nancy Hopkins
Journal:  Genes Dev       Date:  2018-06-26       Impact factor: 11.361

Review 6.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

7.  Body mass index, diet, and exercise: testing possible linkages to breast cancer risk via DNA methylation.

Authors:  Arielle S Gillman; Casey K Gardiner; Claire E Koljack; Angela D Bryan
Journal:  Breast Cancer Res Treat       Date:  2017-11-10       Impact factor: 4.872

Review 8.  Nutrition, inflammation and cancer.

Authors:  Laurence Zitvogel; Federico Pietrocola; Guido Kroemer
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 9.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

Review 10.  Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Authors:  Adi J Klil-Drori; Laurent Azoulay; Michael N Pollak
Journal:  Nat Rev Clin Oncol       Date:  2016-08-09       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.